Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
ClinicalTrials.gov study NCT02971501. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLC
ClinicalTrials.gov study NCT02474355. IPD Sharing: Not stated. Countries: 16. Publications: 3.
The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mut
ClinicalTrials.gov study NCT04179890. IPD Sharing: NO. Countries: 1. Publications: 1.
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00312377. IPD Sharing: Not stated. Countries: 25. Publications: 4.
First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation
ClinicalTrials.gov study NCT00344773. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
ClinicalTrials.gov study NCT02954523. IPD Sharing: NO. Countries: 1. Publications: 1.
ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma
ClinicalTrials.gov study NCT04245085. IPD Sharing: UNDECIDED. Countries: 5. Publications: 1.
A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations
ClinicalTrials.gov study NCT01609543. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment
ClinicalTrials.gov study NCT04820023. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR
ClinicalTrials.gov study NCT01854034. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations
ClinicalTrials.gov study NCT01342965. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation
ClinicalTrials.gov study NCT03414814. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT06463171. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lun
ClinicalTrials.gov study NCT05388669. IPD Sharing: YES. Countries: 20. Publications: 1.
Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors
ClinicalTrials.gov study NCT00709878. IPD Sharing: Not stated. Countries: 1. Publications: 24.
A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR]
ClinicalTrials.gov study NCT01003899. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations
ClinicalTrials.gov study NCT00977470. IPD Sharing: NO. Countries: 1. Publications: 1.
Icotinib for Completed Resected IB NSCLC With EGFR Mutation
ClinicalTrials.gov study NCT02264210. IPD Sharing: Not stated. Countries: 1. Publications: 1.
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
ClinicalTrials.gov study NCT05338970. IPD Sharing: YES. Countries: 21. Publications: 2.
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L
ClinicalTrials.gov study NCT02864251. IPD Sharing: Not stated. Countries: 10. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.